---
title: "Medtronic’s Symplicity Spyral renal denervation system granted US FDA approval for hypertension treatment"
date: "2023-11-19T12:04:41.000Z"
publishedDate: "19 novembre 2023"
summary: "Medtronic has announced approval from the USA Food and Drug Administration (FDA) for the Symplicity Spyral renal denervation (RDN) system for the treatment of hypertension. The company has said that it will immediately begin commercialisation following the approval."
importance: ""
sourceUrl: "https://interventionalnews.com/medtronic-smyplicity-spyral-renal-denervation-us-fda-approval/"
tags: ["France", "Actualité", "Interventional News — Latest"]
permalink: "/papers/2023-11-19-medtronics-symplicity-spyral-renal-denervation-system-granted-us-fda-approval-for-hypertension-treatment"
imageUrl: "https://interventionalnews.com/wp-content/uploads/sites/13/2023/11/Medtronic_plc_RDN_Symplicity_Spyral_Down_Barrel_lyr.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://interventionalnews.com/medtronic-smyplicity-spyral-renal-denervation-us-fda-approval/"
---

![Medtronic’s Symplicity Spyral renal denervation system granted US FDA approval for hypertension treatment](https://interventionalnews.com/wp-content/uploads/sites/13/2023/11/Medtronic_plc_RDN_Symplicity_Spyral_Down_Barrel_lyr.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://interventionalnews.com/medtronic-smyplicity-spyral-renal-denervation-us-fda-approval/*

## L’essentiel

Medtronic has announced approval from the USA Food and Drug Administration (FDA) for the Symplicity Spyral renal denervation (RDN) system for the treatment of hypertension. The company has said that it will immediately begin commercialisation following the approval.

## Lien source

https://interventionalnews.com/medtronic-smyplicity-spyral-renal-denervation-us-fda-approval/
